Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 6, keine Gesamtzahl für „tion“
Suchtreffer
Begriffe & Kennungen
Abecma · 4.8 · The most common adverse reactions (≥ 20%) included CRS (84.6%), neutropenia (80.0%), anaemia (63.6%), thromboc
Eintrag öffnenAbecma · 4.8 · The most common manifestations of CRS (≥ 10%) included pyrexia (82.6%), hypotension (29.1%), tachycardia (24.7
Eintrag öffnenAbecma · 4.8 · The safety data described in this section reflect the exposure to Abecma in the KarMMa, CRB-401 and KarMMa-3 s
Eintrag öffnenAbecma · 4.8 · disturbance in attention, dyscalculia, dysgraphia, encephalopathy, incoherent, lethargy, memory impairment, me
Eintrag öffnenAberglaube
Eintrag öffnenAberrant Motor Behavior in Dementia
Eintrag öffnenAbevmy · 4.1 Therapeutic indications · 1
Eintrag öffnenAbevmy · 4.3 Contraindications · 1
Eintrag öffnenAbevmy · 4.3 · • Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. • Hypersensitivi
Eintrag öffnenAbevmy · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenAbevmy · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenAbevmy · 4.5 · 9 was observed based on the results of population pharmacokinetic analyses. There were neither statistically s
Eintrag öffnenAbevmy · 4.5 · Combination of bevacizumab and sunitinib malate
Eintrag öffnenAbevmy · 4.5 · Combination with platinum- or taxane-based therapies (see sections 4.4 and 4.8)
Eintrag öffnenAbevmy · 4.5 · EGFR monoclonal antibodies in combination with bevacizumab chemotherapy regimens
Eintrag öffnenAbevmy · 4.5 · Increased rates of severe neutropenia, febrile neutropenia, or infection with or without severe neutropenia (i
Eintrag öffnenAbevmy · 4.5 · MAHA is a haemolytic disorder which can present with red cell fragmentation, anaemia, and thrombocytopenia. In
Eintrag öffnenAbevmy · 4.5 · No clinically relevant interaction of bevacizumab was observed on the pharmacokinetics of co- administered int
Eintrag öffnenAbevmy · 4.5 · No clinically relevant interaction of co-administered chemotherapy on bevacizumab pharmacokinetics
Eintrag öffnenAbevmy · 4.5 · No interaction studies have been performed. EGFR monoclonal antibodies should not be administered for the trea
Eintrag öffnen